MedPath

VL-Medi Oy

🇫🇮Finland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?

First Posted Date
2011-09-22
Last Posted Date
2011-09-22
Lead Sponsor
VL-Medi Oy
Target Recruit Count
90
Registration Number
NCT01438736
Locations
🇫🇮

VL Medi Oy, Helsinki, Finland

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.